☆ 4.5 Article

Targeting microglial NLRP3 in the SNc region as a promising disease-modifying therapy for Parkinson's disease

BRAIN AND BEHAVIOR (2022)

Related references

Note: Only part of the references are listed.

Review Biochemistry & Molecular Biology

Biomarker of Neuroinflammation in Parkinson's Disease

Tsai-Wei Liu et al.

Summary: This review summarizes the recent advances in the research on inflammatory biomarkers for Parkinson's disease (PD) detection, as well as monitoring disease progression and treatment response. Neuroinflammation plays a crucial role in the pathogenesis and pathological processes of PD, and various anti-inflammatory medications have demonstrated neuroprotective effects in in vivo or in vitro PD models.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Add to Collection

Review Clinical Neurology

Ten Unsolved Questions About Neuroinflammation in Parkinson's Disease

Etienne C. Hirsch et al.

Summary: Parkinson's disease is a progressive and debilitating disorder with neuroinflammation playing a role in its pathophysiology. Research into the neuroinflammatory processes of Parkinson's disease is ongoing, with many unanswered questions still remaining to be explored for the development of effective treatments.

MOVEMENT DISORDERS (2021)

Add to Collection

Article Immunology

Andrographolide suppresses NLRP3 inflammasome activation in microglia through induction of parkin-mediated mitophagy in in-vitro and in-vivo models of Parkinson disease

Sahabuddin Ahmed et al.

Summary: The communication between microglia activation and dopaminergic neuronal loss plays an important role in the progression of Parkinson's disease. Studying the NLRP3 inflammasome activation and its relation to mitochondrial dysfunction in microglia could provide insights into potential strategies to control neurodegeneration. Mitophagy regulation through Andrographolide treatment may help inhibit NLRP3 activation and rescue dopaminergic neuron loss.

BRAIN BEHAVIOR AND IMMUNITY (2021)

Add to Collection

Review Pharmacology & Pharmacy

Neurodegenerative Disease and the NLRP3 Inflammasome

Jonathan A. Holbrook et al.

Summary: The prevalence of neurodegenerative diseases is increasing, characterized by progressive neuronal loss, protein aggregation, metabolic abnormalities, and immune dysregulation. Research has shown that low-grade systemic inflammation may impact the development and progression of these diseases, and inflammation may also be a causative factor.

FRONTIERS IN PHARMACOLOGY (2021)

Add to Collection

Review Immunology

Targeting Microglial α-Synuclein/TLRs/NF-kappaB/NLRP3 Inflammasome Axis in Parkinson's Disease

Yunna Li et al.

Summary: Recent studies have shown that the excessive activation of microglia and release of pro-inflammatory cytokines play crucial roles in the pathogenesis and progression of Parkinson's disease (PD). The elevated level of NLRP3 inflammasome in activated microglia in the substantia nigra of PD patients exacerbates the pathology and accelerates disease progression. Current therapeutic drugs for PD primarily focus on relieving clinical symptoms, as there are no established strategies to stop or reverse the disease.

FRONTIERS IN IMMUNOLOGY (2021)

Add to Collection

Review Biochemistry & Molecular Biology

The Contribution of Microglia to Neuroinflammation in Parkinson's Disease

Katja Badanjak et al.

Summary: With the aging population, the incidence of Parkinson's disease is increasing, with inflammatory processes playing a major role in its pathology. Microglia have been shown to have a significant neuroprotective role in PD, and the progression of PD may be driven by a vicious cycle between dying neurons and microglia.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Add to Collection

Review Clinical Neurology

Targeting the microglial NLRP3 inflammasome and its role in Parkinson's disease

Md Ezazul Haque et al.

MOVEMENT DISORDERS (2020)

Add to Collection

Article Cell Biology

miR-29c-3p inhibits microglial NLRP3 inflammasome activation by targeting NFAT5 in Parkinson's disease

Ruili Wang et al.

GENES TO CELLS (2020)

Add to Collection

Article Chemistry, Medicinal

Diclofenac 1,3,4-Oxadiazole Derivatives; Biology-Oriented Drug Synthesis (BIODS) in Search of Better Non-Steroidal, Non-Acid Antiinflammatory Agents

Shazia Shah et al.

Medicinal Chemistry (2018)

Add to Collection

Article Cell Biology

Inflammasome inhibition prevents α-synuclein pathology and dopaminergic neurodegeneration in mice

Richard Gordon et al.

SCIENCE TRANSLATIONAL MEDICINE (2018)

Add to Collection

Article Biochemistry & Molecular Biology

Development and Characterization of a Hydroxyl-Sulfonamide Analogue, 5-Chloro-N-[2-(4-hydroxysulfamoyl-phenyl)-ethyl]-2-methoxy-benzamide, as a Novel NLRP3 lnflammasome Inhibitor for Potential Treatment of Multiple Sclerosis

Chunqing Guo et al.

ACS CHEMICAL NEUROSCIENCE (2017)

Add to Collection

Review Immunology

Parkinson's disease: Autoimmunity and neuroinflammation

Armando De Virgilio et al.

AUTOIMMUNITY REVIEWS (2016)

Add to Collection

Article Neurosciences

Atp13a2 Deficiency Aggravates Astrocyte-Mediated Neuroinflammation via NLRP3 Inflammasome Activation

Chen Qiao et al.

CNS NEUROSCIENCE & THERAPEUTICS (2016)

Add to Collection

Article Environmental Sciences

Neuroprotective effects of adenosine isolated from Cordyceps cicadae against oxidative and ER stress damages induced by glutamate in PC12 cells

Opeyemi J. Olatunji et al.

ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY (2016)

Add to Collection

Article Neurosciences

Knockdown of interleukin-1 receptor 1 is not neuroprotective in the 6-hydroxydopamine striatal lesion rat model of Parkinson's disease

Sinead Walsh et al.

INTERNATIONAL JOURNAL OF NEUROSCIENCE (2015)

Add to Collection

Review Cell Biology

Cytokines and Chemokines at the Crossroads of Neuroinflammation, Neurodegeneration, and Neuropathic Pain

Geeta Ramesh et al.

MEDIATORS OF INFLAMMATION (2013)

Add to Collection

Article Chemistry, Multidisciplinary

Asiatic acid, a pentacyclic triterpene in Centella asiatica, attenuates glutamate-induced cognitive deficits in mice and apoptosis in SH-SY5Y cells

Min-fang Xu et al.

ACTA PHARMACOLOGICA SINICA (2012)

Add to Collection

© Peeref 2019-2024. All rights reserved.